期刊论文详细信息
Journal of Cardiothoracic Surgery
An unusual case of giant cell myocarditis missed in a Heartmate-2 left ventricle apical-wedge section: a case report and review of the literature
Anique Ducharme2  Michel White2  Normand Racine2  Mark Liszkowski2  Guy B Pelletier2  Philippe Romeo1  Michel Carrier3  Kim Anderson2 
[1] Department of Pathology, Montreal Heart Institute, University of Montreal, 5000, Belanger East, Montreal, QC, H1T 1C8, Canada;Department of Medicine, Montreal Heart Institute, University of Montreal, 5000, Belanger East, Montreal, QC, H1T 1C8, Canada;Department of Cardiac Surgery, Montreal Heart Institute, University of Montreal, 5000, Belanger East, Montreal, QC, H1T 1C8, Canada
关键词: Left ventricular assist device;    Endomyocardial biopsy;    Heart transplant;    Immunosuppression;    Lymphoma;    Lymphocytic myocarditis;    Giant cell myocarditis;   
Others  :  829456
DOI  :  10.1186/1749-8090-8-12
 received in 2012-09-19, accepted in 2013-01-11,  发布年份 2013
PDF
【 摘 要 】

Herein we present a case of fulminant myocarditis in a woman previously treated for B-cell lymphoma. While the clinical context was suggestive of adriamycin-induced cardiomyopathy, the initial pathology of the Heartmate-2 apical core showed lymphocytic myocarditis. After 8 months of stability, the patient presented with progressive heart failure and recurrent ventricular arrhythmias. An endomyocardial biopsy revealed findings typical of giant cell myocarditis (GCM); poor response to immunosuppressive therapy and marked hemodynamic instability led to urgent transplantation. To our knowledge, this is the first reported case of GCM following an acute lymphocytic myocarditis and the second GCM case associated with B-cell lymphoma.

【 授权许可】

   
2013 Anderson et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140714070427372.pdf 1684KB PDF download
Figure 4. 229KB Image download
Figure 3. 158KB Image download
Figure 2. 136KB Image download
Figure 1. 142KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】
  • [1]Cooper LT Jr, Berry GJ, Shabetai R: Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter giant cell myocarditis study group investigators. N Engl J Med 1997, 336:1860-1866.
  • [2]Cooper LT Jr, Hare JM, Tazelaar HD, Edwards WD, Starling RC, Deng MC, Menon S, Mullen GM, Jaski B, Bailey KR, et al.: Usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol 2008, 102:1535-1539.
  • [3]Davies RA, Veinot JP, Smith S, Struthers C, Hendry P, Masters R: Giant cell myocarditis: clinical presentation, bridge to transplantation with mechanical circulatory support, and long-term outcome. J Heart Lung Transplant 2002, 21:674-679.
  • [4]Hales SA, Theaker JM, Gatter KC: GIant cell myocarditis associated with lymphoma: an immunocytochemical study. J Clin Pathol 1987, 40:1310-1313.
  • [5]Truica CI, Hansen CH, Garvin DF, Meehan KR: Idiopathic giant cell myocarditis after autologous hematopoietic stem cell transplantation and interleukin-2 immunotherapy. Cancer 1998, 83:1231-1236.
  • [6]Kodama M, Hanawa H, Saeki M, Hosono H, Inomata T, Suzuki K, Shibata A: Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ Res 1994, 75:278-284.
  • [7]Zhang S, Kodama M, Hanawa H, Izumi T, Shibata A, Masani F: Effects of cyclosporine, prednisolone and aspirin on rat autoimmune giant cell myocarditis. J Am Coll Cardiol 1993, 21:1254-1260.
  • [8]Hanawa H, Kodama M, Zhang S, Izumi T, Shibata A: An immunosuppressant compound, FK-506, prevents the progression of autoimmune myocarditis in rats. Clin Immunol Immunopathol 1992, 62:321-326.
  • [9]Hanawa H, Kodama M, Inomata T, Izumi T, Shibata A, Tuchida M, Matsumoto Y, Abo T: Anti-alpha beta T cell receptor antibody prevents the progression of experimental autoimmune myocarditis. Clin Exp Immunol 1994, 96:470-475.
  • [10]Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE: A clinical trial of immunosuppressive therapy for myocarditis. The myocarditis treatment trial investigators. N Engl J Med 1995, 333:269-275.
  • [11]Shields RC, Tazelaar HD, Berry GJ, Cooper LT Jr: The role of right ventricular endomyocardial biopsy for idiopathic giant cell myocarditis. J Card Fail 2002, 8:74-78.
  • [12]Miani D, Finato N, Tursi V, Rocco M, Albanese MC, Livi U: Atypical presentation of idiopathic granulomatous myocarditis mimicking idiopathic giant cell myocarditis: diagnostic, therapeutic and prognostic insights. Transpl Int 2008, 21:505-507.
  • [13]Okura Y, Dec GW, Hare JM, Kodama M, Berry GJ, Tazelaar HD, Bailey KR, Cooper LT: A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol 2003, 41:322-329.
  • [14]Grauhan O, Siniawski H, Dandel M, Lehmkuhl H, Knosalla C, Pasic M, Weng YG, Hetzer R: Coronary atherosclerosis of the donor heart–impact on early graft failure. Eur J Cardiothorac Surg 2007, 32:634-638.
  文献评价指标  
  下载次数:27次 浏览次数:13次